Last Updated : August 30, 2018
Details
FilesProject Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Summary with Critical Appraisal
Project Number:
RC1010-000
Question
- What are the evidence-based guidelines regarding the use of opioid addiction programs for the treatment of adults who are reducing or discontinuing opioids or opioid substitution therapy?
Key Message
Six evidence-based guidelines were identified regarding the use of programs for the treatment of opioid use disorders in adults. Included guidelines provide recommendations regarding the safety and clinical effectiveness of programs that address treatment, implementation, and adherence enhancement strategies. Two Canadian guidelines recommend initiating opioid agonist treatment with buprenorphine/naloxone where feasible as a first-line treatment option. This was a strong recommendation based on high quality evidence. Alternative strategies are recommended where buprenorphine/naloxone is not feasible, or where contraindications are identified. Psychosocial interventions aimed at reducing illicit drug use during detoxification and following completion include fostering social support (with the service provider, with peer groups and with existing network of family and carers) and use of contingency management.
Files
Last Updated : August 30, 2018